- Home
- LXRX vs DIN Comparison
LXRX vs DIN Comparison
Compare LXRX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- DIN
- Stock Information
- Founded
- LXRX 1995
- DIN 1958
- Country
- LXRX United States
- DIN United States
- Employees
- LXRX N/A
- DIN N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- LXRX Health Care
- DIN Consumer Discretionary
- Exchange
- LXRX Nasdaq
- DIN Nasdaq
- Market Cap
- LXRX 428.8M
- DIN 379.1M
- IPO Year
- LXRX 2000
- DIN 1991
- Fundamental
- Price
- LXRX $1.19
- DIN $22.36
- Analyst Decision
- LXRX Buy
- DIN Hold
- Analyst Count
- LXRX 5
- DIN 9
- Target Price
- LXRX $3.23
- DIN $26.57
- AVG Volume (30 Days)
- LXRX 2.4M
- DIN 555.6K
- Earning Date
- LXRX 08-06-2025
- DIN 08-06-2025
- Dividend Yield
- LXRX N/A
- DIN 9.12%
- EPS Growth
- LXRX N/A
- DIN N/A
- EPS
- LXRX N/A
- DIN 2.99
- Revenue
- LXRX $58,432,000.00
- DIN $845,368,000.00
- Revenue This Year
- LXRX N/A
- DIN $8.62
- Revenue Next Year
- LXRX N/A
- DIN $1.82
- P/E Ratio
- LXRX N/A
- DIN $7.49
- Revenue Growth
- LXRX 1504.83
- DIN 2.92
- 52 Week Low
- LXRX $0.28
- DIN $18.63
- 52 Week High
- LXRX $2.18
- DIN $37.44
- Technical
- Relative Strength Index (RSI)
- LXRX 56.85
- DIN 50.36
- Support Level
- LXRX $1.12
- DIN $20.80
- Resistance Level
- LXRX $1.27
- DIN $22.11
- Average True Range (ATR)
- LXRX 0.09
- DIN 0.85
- MACD
- LXRX -0.00
- DIN 0.18
- Stochastic Oscillator
- LXRX 68.00
- DIN 77.66
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.